Novel androgen therapies including selective androgen receptor modulators

被引：6
|
作者：
Kang, Jungwoo [1 ]
Chen, Runzhi [2 ]
Tharakan, Tharu [1 ]
Minhas, Suks [3 ]
机构：
[1] London Northwest Univ Healthcare NHS Trust, Northwick Pk Hosp, Dept Urol, Harrow HA1 3UJ, England
[2] Imperial Coll London, Fac Med, Sir Alexander Fleming Bldg,Imperial Coll Rd, London SW7 2AZ, England
[3] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Urol, London W6 8RF, England
来源：
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM | 2022年 / 36卷 / 05期
关键词：
male hypogonadism; testosterone replacement therapy; novel androgen therapies; nasal testosterone; TESTOSTERONE REPLACEMENT THERAPY; CONTRACEPTIVE EFFICACY; INFLAMMATORY CYTOKINES; AROMATASE INHIBITION; CLOMIPHENE CITRATE; HYPOGONADAL MEN; DOUBLE-BLIND; ELDERLY-MEN; RISK-FACTOR; OLDER MEN;
D O I：
10.1016/j.beem.2022.101686
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Male hypogonadism is associated with reduced quality of life and the development of co-morbidities including obesity, diabetes mellitus, and dyslipidaemia. The mainstay of treatment for male hypogonadism is testosterone replacement therapy (TRT). How-ever, TRT has recognised side effects including impaired sper-matogenesis and there are concerns regarding its use in men with concurrent cardiovascular disease. Thus, there has been an impetus to develop novel androgen therapies for treating male hypogonadism to mitigate the side effects of TRT. This review will discuss the benefits and adverse effects of TRT, and novel therapies including nasal testosterone, aromatase inhibitors, selective oes-trogen receptor modulators, and selective androgen receptor modulators.(c) 2022 Elsevier Ltd. All rights reserved.
引用
收藏
页数：17
相关论文
共 50 条
  • [41] Androgen Receptor and Cardiovascular Disease: A Potential Risk for the Abuse of Supplements Containing Selective Androgen Receptor Modulators
    Hall, Ellis
    Vrolijk, Misha F. F.
    NUTRIENTS, 2023, 15 (15)
  • [42] Potent, nonsteroidal androgen receptor modulators based on 2-quinolinone scaffolds: A platform for selective androgen receptor modulators (SARMS).
    Higuchi, RI
    Zhi, L
    Edwards, JP
    Caferro, TR
    Ringgenberg, JD
    West, SJ
    Kong, JW
    Hamann, LG
    Arienti, KL
    Cummings, ML
    Wu, M
    Tegley, CM
    Jones, TK
    Lopez, FJ
    Marschke, KB
    Schrader, WT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U537 - U538
  • [43] Selective androgen receptor modulators: In pursuit of tissue-selective androgens
    Omwancha, Josephat
    Brown, Terry R.
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (10) : 873 - 881
  • [44] Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs). Part I
    Aikawa, Katsuji
    Miyawaki, Toshio
    Hitaka, Takenori
    Imai, Yumi N.
    Hara, Takahito
    Miyazaki, Junichi
    Yamaoka, Masuo
    Kusaka, Masami
    Kanzaki, Naoyuki
    Tasaka, Akihiro
    Shiraishi, Mitsuru
    Yamamoto, Satoshi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (10) : 2568 - 2578
  • [45] Selective Androgen Receptor Modulators: Current Knowledge and Clinical Applications
    Solomon, Zachary J.
    Mirabal, Jorge Rivera
    Mazur, Daniel J.
    Kohn, Taylor P.
    Lipshultz, Larry I.
    Pastuszak, Alexander W.
    SEXUAL MEDICINE REVIEWS, 2019, 7 (01) : 84 - 94
  • [46] Development of new tissue-selective androgen receptor modulators
    Grootenhuis, A. J.
    INTERNATIONAL JOURNAL OF ANDROLOGY, 2005, 28 : 19 - 19
  • [47] Combination of selective androgen and estrogen receptor modulators in orchiectomized rats
    Roch, P. J.
    Wolgast, V
    Gebhardt, M-M
    Boeker, K. O.
    Hoffmann, D. B.
    Saul, D.
    Schilling, A. F.
    Sehmisch, S.
    Komrakova, M.
    JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2022, 45 (08) : 1555 - 1568
  • [48] Nonsteroidal Selective Androgen Receptor Modulators (SARMs): Dissociating the Anabolic and Androgenic Activities of the Androgen Receptor for Therapeutic Benefit
    Mohler, Michael L.
    Bohl, Casey E.
    Jones, Amanda
    Coss, Christopher C.
    Narayanan, Ramesh
    He, Yali
    Hwang, Dong Jin
    Dalton, James T.
    Miller, Duane D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (12) : 3597 - 3617
  • [49] Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth
    Nyquist, Michael D.
    Ang, Lisa S.
    Corella, Alexandra
    Coleman, Ilsa M.
    Meers, Michael P.
    Christiani, Anthony J.
    Pierce, Cordell
    Janssens, Derek H.
    Meade, Hannah E.
    Bose, Arnab
    Brady, Lauren
    Howard, Timothy
    De Sarkar, Navonil
    Frank, Sander B.
    Dumpit, Ruth F.
    Dalton, James T.
    Corey, Eva
    Plymate, Stephen R.
    Haffner, Michael C.
    Mostaghel, Elahe A.
    Nelson, Peter S.
    JOURNAL OF CLINICAL INVESTIGATION, 2021, 131 (10):
  • [50] Optimizing ligand efficiency of selective androgen receptor modulators (SARMs)
    Handlon, Anthony
    Cadilla, Rodolfo
    Leesnitzer, Lisa
    Merrihew, Raymond
    Poole, Chuck
    Ulrich, John
    Wilson, Joseph
    Turnbull, Philip
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
12345